A Study of AB-1005 Gene Therapy in Japanese Adults With Moderate Parkinson's Disease (J-REGENERATE-PD)
A Study of AB-1005 Gene Therapy in Japanese Adults With Moderate Parkinson's Disease (J-REGENERATE-PD)
Not yet recruiting · NCT07566429 · Registry updated 2026-07-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of AB-1005 Gene Therapy in Japanese Adults With Moderate Parkinson's Disease (J-REGENERATE-PD) | Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Not yet recruiting | Phase 2 | 2026-07-29 | NCT07566429 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AskBio Inc | 8 |
| Bayer | 178 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Juntendo University Hospital - Neurology | Bunkyo-ku | Japan | 1 |
| Nagoya Central Hospital - Neurosurgery | Nagoya | Japan | 1 |
| Nagoya University Hospital - Neurology | Nagoya | Japan | 1 |
| National Hospital Organization Osaka Toneyama Medical Center - Neurology | Toyonaka | Japan | 1 |
| National Hospital Organization Utano National Hospital - Neurology | Kyoto | Japan | 1 |
| Yokohama City University Medical Center - Neurology | Yokohama | Japan | 1 |